A529 duration of known diabetes was 6.80 ± 6.67 years. A substantial negative impact of diabetes on the participants' HRQoL was observed as assessed by the ADDQoL (mean ± SD average weighted impact (AWI) score: −3.76 ± 2.03 from the possible range −9 to +3), although the level of their TS was rather high as assessed by the DTSQs (mean ± SD TS scale total: 28.60 ± 5.53 out of 36). The participants' EQ-5D scores (mean ± SD EQ-utility score: 0.74 ± 0.20; EQ-VAS score: 65.22 ± 17.54) were only slightly lower than the norm values for the general population (0.80 ± 0.26 and 79.74 ± 18.23 for the two scores, respectively). Higher income was signifi cantly associated with better health status while lower education and unemployment status were signifi cantly associated with poorer HRQoL. Female gender and older age were associated with higher TS. CON-CLUSIONS: Diabetes had major impact on the participants' HRQoL but little impact on health status despite a high level of TS. Patient characteristics associated with these outcomes were also different.
1
Department of Pharmacy, National University of Singapore, Singapore; 2 University of Newcastle, Callaghan, NSW, Australia OBJECTIVES: To develop a Thai version of the Audit of Diabetes-Dependent Quality of Life and to evaluate its psychometric properties among Thai patients with diabetes. METHODS: This study was conducted by fi rstly cross-culturally adapting the original English ADDQoL-19 into Thai, followed by administering the Thai version together with the Thai EQ-5D and sociodemographic questionnaire to patients (aged >18 years) with diabetes recruited from a tertiary hospital in central Thailand by simple random sampling. The usefulness of a 'not applicable' (N/A) option and the necessary of weighting the impact scores, factor structure and internal consistency reliability of the Thai ADDQoL-19 were assessed. Data were subjected to confi rmatory factor analysis (CFA) using structural equation modeling (SEM) and exploratory factor analysis (EFA) using principal component analysis (PCA). The known-groups validity of the Thai ADDQoL was assessed by four a priori hypotheses. RESULTS: The Thai ADDQoL-19 was shown to be conceptually equivalent to its original version and culturally relevant to Thai patients with diabetes. Its psychometric properties were evaluated among 201 diabetic patients (71.1% females; 81.6% primary educated; mean age 54.25 [SD = 9.8] years). Its unique characteristics, i.e., weighting and individualization were proved to be necessary for a more accurate assessment of quality of life. The Thai ADDQoL-19 also demonstrated a good internal consistency reliability, with the Cronbach's alpha of 0.90. However, the fi t indices derived from a CFA failed to achieve a good fi t (i.e., >0.90). EFA with forced-one factor solution showed factor loadings above 0.40 for all items, except for sexual relationship. The known-groups validity was also not clear as only two hypotheses were fully fulfi lled. CONCLUSIONS: The Thai ADDQoL-19 has shown to be culturally appropriate and highly reliable but requires further investigations to provide more evidence on its factor structure and known-groups validity before its utilization in routine clinical settings.
PDB17 EVALUATING THE CHOICE OF PEN VERSUS SYRINGE: IMPLICATIONS FOR LONG-TERM DIABETES MANAGEMENT
Brod M 1 , Thomsen TL 2 , Christensen T 2 1 The Brod Group, Mill Valley, CA, USA; 2 Novo Nordisk A/S, Virum, Denmark OBJECTIVES: The two most commonly used insulin delivery devices, pens and syringes, have comparable safety profi les and effi cacy under similar use conditions. Therefore, the decision regarding the preferred device must be based on other considerations such as treatment satisfaction, treatment adherence, health-related quality of life (HRQoL), health-care expenditure and utilization. METHODS: A literature search was conducted of published articles in peer reviewed journals listed in the US National Library of Medicine's PubMed (1948-present) , DIALOG including PsychInfo (1887present), EMCARE (nursing lit., 1995-present) , BIOSIS (1993-present) , EMBASE (Excerpta Medica, 1974-present) , SciSearch (1990-present) and MEDLINE. Relevant manuscripts were classifi ed into subcategories based on the major focus of the article reviewed and then subcategories were collapsed into major categories: treatment satisfaction, treatment adherence, HRQoL, and health-care expenditure and utilization. RESULTS: A total of 135 publications were reviewed for inclusion of which 73 manuscripts and nine conference abstracts/poster were deemed relevant and reviewed in depth. Seventeen reported fi ndings from clinical trials and 13 were review articles. There is substantial evidence demonstrating the superior benefi ts of pens over syringes. Treatment satisfaction and patient preference for pens over syringes was widely reported and patients reported that pens provided them with increased confi dence in dose, ability to self-inject, superior convenience and overall ease of use. Pen users reported better treatment adherence and fewer missed insulin doses which may account for the reported better HbA1c control than with syringe. Health-care expenditure and utilization were higher in the short term for pens; however, these expenditures were minor in comparison with long-term savings that result from improved decreases in hospitalizations, incidence of side effects, physician visits and emergency department visits. CONCLUSIONS: Long-and short-term diabetes management should benefi t from the choice of pen as the insulin delivery method based on PRO outcomes and long term cost effectiveness.
PDB18 THE PREVALENCE AND IMPACT OF BEING AT-RISK FOR DIABETES ACROSS US, JAPAN, AND EUROPE
DiBonaventura MD 1 , Iwamoto K 2 , Nakahara N 3 , Fukuda T 4 , Nagae T 5 , Wagner JS 1 , Stankus A 6 1 Kantar Health, New York, NY, USA; 2 Eli Lilly Japan K.K., Chuo-ku, Kobe, Japan; 3 Eli Lilly Japan K.K., Kobe, Japan; 4 Tokyo University, Tokyo, Japan; 5 York Pharma KK, Tokyo, Japan; 6 Kantar Health, Princeton, NJ, USA OBJECTIVES: As diabetes rates rise, it is important to understand the profi le of those who are at-risk for developing diabetes but have not yet been diagnosed. The aim of this study was to assess the burden for these high-risk patients. METHODS: The current study used US 2009, EU 2008, and Japan 2008 datasets from the National Health and Wellness Survey (NHWS). Implementing a previously-developed algorithm, all patients not diagnosed with diabetes were classifi ed as having or not having a high risk for developing diabetes. High-risk patients were compared with controls on health-related quality of life (physical component summary (PCS) scores of the SF-12v2) and the number of emergency room (ER) visits controlling for demographics (country, age, gender, ethnicity, income, education) and patient characteristics (BMI and Charlson comorbidity index). RESULTS: Of patients not diagnosed with diabetes, 16.64% (n = 10778) in the United States, 14.33% (n = 7481) in the EU, and 4.05% (n = 750) in Japan were classifi ed as being at high risk for diabetes. After controlling for demographics and patient characteristics, those at high risk reported signifi cantly lower levels of PCS across all three countries (Adjusted Mean [Madj] = 46.2 vs. 49.6, P < 0.0001) than controls. The effect was stronger in the EU (M-adj = 45.5 vs. M-adj = 49.2) and weaker in Japan (M-adj = 47.9 vs. M-adj = 49.8) relative to the United States (M-adj = 46.6 vs. M-adj = 49.7). Those at high risk reported signifi cantly fewer ER visits (Madj = 0.12 vs. M-adj = 0.16, P < 0.0001) than controls, however, this effect was reversed in Japan in that those at high risk reported signifi cantly more ER visits than controls (M-adj = 0.21 vs. M-adj = 0.12, P < 0.0001). CONCLUSIONS: A substantial number of patients are at a high risk for developing diabetes, particularly in the United States and EU. The physical quality of life was signifi cantly lower, particularly in the EU and the United States, and in Japan this group reported signifi cantly more ER visits than controls.
PDB19

HEALTH-RELATED QUALITY OF LIFE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Shim YT 1 , Ko Y 1 , Lee JYC 2 , Tang WE 3 , Toh MPHS 3 1 National University of Singapore, Singapore; 2 National University of Singapore, Singapore; 3 National Healthcare Group Polyclinics, Singapore OBJECTIVES: Diabetes Mellitus (DM) can reduce patients' physical well-being and compromise other aspects of quality of life. This study aims to investigate the healthrelated quality of life (HRQoL) of DM patients under primary care, and the associations of HRQoL with demographic factors and HbA1c control. Previous studies that examined these associations yielded mixed results and none was done in Singapore. METHODS: A cross-sectional, interviewer-administered survey was conducted in either English or Chinese, depending on the patient's language of preference, between September and December 2009 in a convenience sample of 301 DM patients who were ≥21 years old, on hypoglycemic agent(s), with at least a year of DM history, and followed up at two outpatient clinics. Survey instrument included demographic questions and one generic and one DM-specifi c HRQoL measures, i.e., EQ-5D and the Audit of Diabetes-Dependent Quality of Life (ADDQoL), respectively. Patients' most recent HbA1c values were extracted from medical records in the clinics. RESULTS: The average EQ-5D score was 0.89 ± 0.16 and ADDQoL average weighted impact (AWI) score was −2.5 ± 2.0. Pain was the most common complaint among the fi ve EQ-5D domains (by 28% of the respondents). Lack of freedom to eat was the ADDQoL domain with the greatest negative impact (AWI = −3.8, on a scale of −9 to 3). A signifi cant association was observed between ADDQoL AWI and both duration of diabetes (P = 0.005) and use of insulin (P = 0.014). A negative correlation was found between HRQoL and HbA1c values in both HRQoL measures (both r = −0.2, P < 0.01). CONCLUSIONS: DM patients in primary care settings frequently reported problems with pain and restrictions in diet. Poorer HRQoL was found to be associated with higher HbA1c, which indicates poorer glycemic control. The chronicity of DM and use of insulin may have negative impact on patients' HRQoL.
PDB20 OLDER WOMEN WITH DIABETES: CARDIOVASCULAR MEDICATION USE AND QUALITY OF LIFE
Hikmayani NH 1 , Robertson J 2 , Dolja-Gore X 3 1 Sebelas Maret University, Solo, Central Java, Indonesia; 2 The University of Newcastle, Waratah, NSW, Australia; 3 Research Centre for Gender, Health and Ageing, Newcastle, NSW, Australia OBJECTIVES: To examine the association between patterns of cardiovascular medication use and health-related quality of life (HRQoL) in elderly Australian women with diabetes. METHODS: A cross-sectional study was conducted using older cohort completing Survey 4 in the Australian Longitudinal Study on Women's Health (ALSWH) who self-reported to have been diagnosed with diabetes and/or use medications indicative of diabetes. Use of cardiovascular medications was identifi ed from self-reported medications belonging to the Anatomical Therapeutic Chemical (ATC) code B01AC, C03, C07, C08, C09, C02 and C10. Usage patterns were classifi ed as no use, using any hypertensives, lipid lowering agents or antiplatelet drugs, using any two classes, and using all the three classes. The SF-36 was used to measure HRQoL, focusing on the
